These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32934044)

  • 1. Modulating the gut-liver axis and the pivotal role of the faecal microbiome in cirrhosis.
    Woodhouse C; Singanayagam A; Patel VC
    Clin Med (Lond); 2020 Sep; 20(5):493-500. PubMed ID: 32934044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota, cirrhosis, and the emerging oral-gut-liver axis.
    Acharya C; Sahingur SE; Bajaj JS
    JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
    Albillos A; de Gottardi A; Rescigno M
    J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promises of microbiome-based therapies.
    Bajaj JS; Ng SC; Schnabl B
    J Hepatol; 2022 Jun; 76(6):1379-1391. PubMed ID: 35589257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gut microbiota-bile acid axis in cholestatic liver disease.
    Sun D; Xie C; Zhao Y; Liao J; Li S; Zhang Y; Wang D; Hua K; Gu Y; Du J; Huang G; Huang J
    Mol Med; 2024 Jul; 30(1):104. PubMed ID: 39030473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy
    Luo M; Xin RJ; Hu FR; Yao L; Hu SJ; Bai FH
    World J Gastroenterol; 2023 Jan; 29(1):144-156. PubMed ID: 36683714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut-liver axis in immune remodeling of hepatic cirrhosis.
    Guan H; Zhang X; Kuang M; Yu J
    Front Immunol; 2022; 13():946628. PubMed ID: 37408838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis.
    Maslennikov R; Ivashkin V; Efremova I; Poluektova E; Kudryavtseva A; Krasnov G
    World J Gastroenterol; 2022 Mar; 28(10):1067-1077. PubMed ID: 35431497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Microbiome in Patients With Cirrhosis and Complications.
    Acharya C; Bajaj JS
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):307-321. PubMed ID: 30099098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis.
    Bajaj JS; Khoruts A
    J Hepatol; 2020 May; 72(5):1003-1027. PubMed ID: 32004593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intestinal microbiota on liver disease and its related future prospection: From the perspective of intestinal barrier damage and microbial metabolites.
    Jiang N; Xiao Y; Yuan K; Wang Z
    J Gastroenterol Hepatol; 2023 Jul; 38(7):1056-1071. PubMed ID: 36662612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human microbiome and gut-liver axis in people living with HIV.
    Duarte MJ; Tien PC; Somsouk M; Price JC
    Curr HIV/AIDS Rep; 2023 Jun; 20(3):170-180. PubMed ID: 37129834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota and Complications of Liver Disease.
    Acharya C; Bajaj JS
    Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Link between Gut Microbiota and Hepatic Encephalopathy.
    Won SM; Oh KK; Gupta H; Ganesan R; Sharma SP; Jeong JJ; Yoon SJ; Jeong MK; Min BH; Hyun JY; Park HJ; Eom JA; Lee SB; Cha MG; Kwon GH; Choi MR; Kim DJ; Suk KT
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol, liver disease and the gut microbiota.
    Bajaj JS
    Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
    Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
    Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of the Gut Microbiome in Liver Cirrhosis Treatment.
    Lee NY; Suk KT
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
    Arab JP; Martin-Mateos RM; Shah VH
    Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis.
    Nishikawa H; Enomoto H; Nishiguchi S; Iijima H
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.